Abstract
The extent to which obesity compromises the differentiation and maintenance of protective memory CD8 T cell responses and renders obese individuals susceptible to infection remains unknown. Here, we show that diet-induced obesity did not impact the maintenance of pre-existing memory CD8 T cells including acquisition of a long-term memory phenotype (i.e. CD27hi, CD62Lhi, KLRG1low) and function (i.e. cytokine production, secondary expansion, and memory CD8 T cell-mediated protection). In addition, obesity did not influence the differentiation and maintenance of newly evoked memory CD8 T cell responses in inbred and outbred hosts generated in response to different types of systemic (LCMV, L. monocytogenes) and/or localized (influenza virus) infections. Interestingly, the rate of naïve-to-memory CD8 T cell differentiation after a peptide-coated dendritic cell (DC) immunization was similar in lean and obese hosts suggesting that obesity associated inflammation, unlike pathogen- or adjuvant-induced inflammation, did not influence the development of endogenous memory CD8 T cell responses. Therefore, our studies reveal that the obese environment does not influence the development or maintenance of memory CD8 T cell responses that are either primed before or after obesity is established, a surprising notion with important implications for future studies aiming to elucidate the role obesity plays in host susceptibility to infections.
Introduction
The obesity epidemic is a public health concern currently affecting more than 30% of the adult population in the United States (1, 2) and obese individuals have a higher chance of developing coronary heart disease, several types of cancer, and type 2 diabetes (3–9). The rate of childhood and adolescent obesity is also increasing at a startling rate (currently affecting 18% of children and 21% of adolescents in the United States), suggesting that as these youth age, they are more likely to become obese as adults and develop associated health problems (10). Alarmingly, overweight and obesity are considered leading risk factors for global deaths, indicating the worldwide impact of this condition (11).
Recent studies have shown that obesity increases susceptibility to infection. For example, during the H1N1 influenza pandemic, obesity was found to be an independent risk factor associated with increased morbidity and mortality, as obese individuals were more likely to become admitted into the ICU and succumb to death (12). Obese hosts are also predisposed to pneumonia because of reduced lung volumes and altered ventilation patterns (13). Improper wound healing renders obese patients susceptible to nosocomial infections at surgical sites (14, 15). In addition to being a factor that increases susceptibility to infection, obesity is also associated with decreased vaccine efficacy. The first documented association between obesity and poor antibody responses was found after hepatitis B plasma vaccine administration in hospital personnel (16). Compared to lean youth, obese children and adolescents were found to have reduced anti-tetanus antibody titers (17). Furthermore, after inactivated trivalent influenza vaccination, humans with a higher body mass index had a greater decline in influenza-specific antibody titers a year after immunization (18). These data suggest that obese individuals are not only more susceptible to infection, but also may not be receiving the full benefits of current vaccine protocols.
Recently, vaccination strategies aiming to elicit a robust memory CD8 T cell response have gained recognition as an avenue to control infectious diseases that are resistant to antibody-based vaccines (19–21). Following an acute infection or vaccination, memory CD8 T cells are generated from a low number of naïve Ag-specific precursors that have undergone vigorous clonal expansion and contraction phases(19, 20, 22, 23). In addition to persisting at higher numbers in a host, memory CD8 T cells possess the unique ability to rapidly respond to re-infection and kill pathogen-infected cells by initiating effector functions such as cytokine production and the release of perforin and granzyme (24). Importantly, the degree of CD8 T cell-mediated protection correlates with the number of memory CD8 T cells present in vivo and their functional characteristics (25–27).
Recent studies showed that the inflammation present early after Ag encounter influences the homeostasis of primary Ag-specific CD8 T cell responses, including the magnitude of proliferative expansion as well as the rat eat which Ag-specific CD8 T cells acquire memory CD8 T cell characteristics (19, 28–33). Interestingly, obesity as a multi-factorial disease is associated with low-grade systemic inflammation that can potentially influence naïve-to-memory CD8 T cell differentiation. It has been shown that visceral adipocytes and macrophages infiltrating growing adipose tissue of obese individuals secrete increased levels of cytokines and chemokines, such as TNFα and CCL2, triggering this systemic inflammation (34–36). The hypertrophic changes that allow adipose tissue expansion result in adipocyte cell death and the release of ATP and uric acid, which serve as danger signals to alert the immune system of metabolic changes taking place in the host(6, 37). The local adipose tissue environment of obese hosts not only initiates continuous infiltration of macrophages, but also promotes their acquisition of a pro-inflammatory M1 polarized status because of already increased levels of TNFα within expanding adipose tissue (38–40). Importantly, the extent to which obesity-associated changes in the environment influence pre-existing or de novo generated memory CD8 T cell responses is currently unknown.
Here, using a diet-induced obesity model we show that obesity does not influence the generation, long-term maintenance, and function of memory CD8 T cell responses induced either by systemic or localized viral and bacterial infections, or by immunization with peptide-coated dendritic cells.
Materials and Methods
Mice and Diet-Induced Obesity
Inbred male C57BL/6 (B6 Thy1.2+/1.2+), female BALB/c, and female outbred Swiss Webster (SW) mice, were purchased from the National Cancer Institute (NCI) and housed under specific pathogen-free conditions. At 6–12 weeks of age, mice were assigned at random to either receive ad libitum standard chow diet (Harlan Teklad number 7913, 6.2% kcal from fat) or high-fat diet (HFD, Research Diets number 12492, 60% kcal from fat) for indicated times before the start of an experiment, unless otherwise noted, and then throughout the duration of an experiment. Mice receiving HFD are considered obese if body weight is greater than 3 SD above the mean weight of the lean group (41). Thy1.1+/1.2− P14 and Thy1.1+/1.2 OT-I+ (specific for lymphocytic choriomening it is virus (LCMV)-derived GP33 and chicken ovalbumin Ova257 epitopes, respectively) T-cell-receptor transgenic (TCR-Tg) mice were bred at the University of Iowa and described previously (29). All animal procedures followed approved Institutional Animal Care and Use Committee (ACURF) protocols.
Pathogens
The Armstrong strain of LCMV (LCMV, 2×105 PFU/mouse, i.p.) and the virulent Listeria monocytogenes (LM) strains expressing Ova257 (Vir LM-Ova, 5×104 CFU/mouse, i.v.), GP33 (Vir LM-GP33, 2×105 CFU/mouse, i.v.) and attenuated actA-deficient L. monocytogenes strain expressing Ova257 (Att LM-OVA, 5×106 CFU/mouse, i.v.) were grown, injected, and quantified as described (25, 26, 42, 43). Mouse-adapted Influenza A viruses A/PR/8/34 and X-31 (IAV, PR8 and X-31, 2.75×102 tissue culture infectious units (TCIU) of virus/mouse, i.n.) were prepared from stocks, as previously described(44). Mice were first anesthetized and given a primary infection with IAV strain PR8 and then challenged 30 days later with IAV strain X-31. Infected mice were housed at the University of Iowa under the appropriate biosafety level.
Adoptive transfer and isolation of lymphocytes from tissue
Thy1.1+/1.2− P14 and Thy1.1+/1.2+ OT-I CD8 T cells were obtained from peripheral blood samples of young naïve TCR-Tg P14 and OT-I mice, respectively. Contaminating memory phenotype (CD44hi CD11ahi) P14 and OT-I cells were always <5%. Naïve P14 CD8 T cells were injected (5×103 cells/mouse, i.v.) into naïve B6 (Thy1.2+/1.2+) recipients. Naïve OT-I CD8 T cells were injected (1×103 cells/mouse, i.v.) into LCMV immune lean and obese B6 (Thy1.2+/1.2+) recipients.
Before removal of secondary lymphoid organs and tertiary tissues, samples of blood were obtained by retro-orbital puncture. Anesthetized mice were then perfused through the left ventricle with cold PBS and tissues including spleen, lymph node (LN), and lung were collected. Single-cell suspensions from spleen and LN were washed before Ab staining. Lungs were first cut into small pieces and treated with collagenase D (125U/mL) and DNAse I for 30 min at 37°C before further processing and Ab staining.
Antibodies and peptides
Flow cytometry data was acquired on a FACSCanto flow cytometer (Beckton-Dickinson Biosciences) and analyzed with FlowJo software (Tree Star). The following is a list of used mAbs with the indicated specificity and appropriate combinations in fluorochromes from eBioscience: CD8 (clone 53–6.7), Thy1.1 (HIS51), Thy1.2 (53–2.1), CD11a (M17/4), CD27 (LG.759), CD62L (MEL-14), KLRG1 (2F1), CD127 (A7R34), and appropriate isotype controls. Intracellular staining for mAb IFNγ (XMG1.2, Biolegend), TNFα (MP6-XT22, Biolegend), IL-2 (JES6–5H4, eBioscience), Granzyme B (Invitrogen, FGB12), and appropriate isotype control was performed after surface fixation and permeabilization of the cell membrane using cytofix/cytoperm solution. To assess degranulation, we added FITC-conjugated CD107a (1D48, eBioscience) or isotype control and monensin A to cells during the stimulation period as previously described (45). Synthetic GP33–41 and Ova257–264 peptides were used as previously described (30, 46).
Quantification of CD8 T cell responses and intracellular cytokine staining
P14 and OT-I cell responses in the peripheral blood and tissues were monitored by FACS analysis for Thy1.1+/1.2− and Thy1.1+/1.2+ positive CD8 T cells. Endogenous GP33-and Ova257-specific CD8 T cells were detected by allophycocyanin-conjugated tetramer complexes as previously described (30). Endogenous IAV NP366 and PA224-specific CD8 T cells were detected by allophycocyanin-conjugated tetramer complexes obtained from the National Institutes of Health and Tetramer Core Facility (Atlanta, GA)(47). Additionally, pathogen-specific CD8 T cells were identified in infected outbred SW mice using a’surrogate activation marker approach’ as previously described (48). Briefly, differences in expression of CD11a and CD8α were used to distinguish Ag-experienced (CD11ahi CD8αlow) from naïve (CD11alow CD8αhi) CD8 T cells. Cells were incubated with mAb at 4°C for 30 min, washed with FACS buffer (PBS containing 1% FCS and 0.1% NaN3), and then fixed with cytofix/cytoperm solution. The percentage of CD8 T cells producing cytokines after stimulation with GP33 or Ova257 peptides was determined using intracellular cytokine staining for IFNγ, TNFα, IL-2, and Granzyme B, after 5h incubation in brefeldin A with or without indicated peptides. For intracellular cytokine staining of lymphocytes isolated from peripheral blood, thymoma tumor cell-line derived EL-4 cells (H-2b MHC) were used as antigen-presenting cells.
Bacterial titers
Bacterial titers were determined as previously described (30). Briefly, tissue was harvested from infected mice at the indicated time after challenge and placed into 4 mL of 0.2% IGEPAL buffer (Sigma-Aldrich) and sterile deionized water. A homogenizer was used and resulting suspension was incubated at room temperature for 1h. Serial dilutions were plated in streptomycin agar plates to quantify bacterial load. The dashed line indicates the limit of detection, LOD.
Dendritic cell immunizations
Splenic dendritic cells (DCs) were isolated after s.c. injection of B6 or BALB/c mice with 5×106 B16 cells expressing Flt3L as previously described(32, 49). When tumors were palpable (5 × 5 mm), mice were injected with 2 μg LPS (Sigma-Aldrich) i.v. to mature the DCs. Spleens were harvested 16h later and digested with DNAse and collagenase for 20 min at 37°C/5% CO2 with shaking (120 RPM). Spleen pieces were smashed through a nylon cell strainer (70 μm) to generate a single-cell suspension, RBCs were lysed, and splenocytes were suspended in 2 parts 10% FCS RPMI 1640 to 1 part B16-Flt3L-conditioned media + rGM-CSF (1000 U/mL) plus 2 μM Ova257- 264 or CS252–260, respectively, and incubated 2h at 37°C/5%CO2 with shaking (100 RPM). Spleen cells were washed three times and CD11c+ cells were isolated using anti-CD11c microbeads (Miltyni Biotec). Routinely, >90% pure CD11c+ DCs were obtained. DCs were resuspended in saline and injected i.v. at 5×105 to 1×106 per mouse.
Cytokine and chemokines evaluation by BioPlex
Plasma samples were obtained from lean and obese mice. Plasma concentrations of the indicated cytokines and chemokines were determined via Multiplex analysis (Procarta Plex; Affymetrix by eBioscience) on a Bio-Rad BioPlex.
Statistical Analyses
Data were analyzed with Prism4 GraphPad software to determine statistical significance as indicated in figure legends. Statistical significance was assessed using the two-tailed, unpaired student’s T test, with a confidence interval >95% (*p ≤ 0.05, **p ≤ 0.005, ***p ≤ 0.001. and n.s. as no significance). Data presented as bar graphs are presented as mean±SEM, unless otherwise noted. Representative dot plots and histograms are presented as mean±SEM. Weight graphs are presented as scatter dot plots with mean±SD.
Results
Diet-induced obesity does not impact the maintenance of pre-existing memory CD8 T cells
The maintenance of memory CD8 T cells is a dynamic process that includes time-dependent changes in phenotype and function (20, 50–52) and in the absence of cognate Ag stimulation memory CD8 T cells can remain stable in numbers for the life of the laboratory mouse (53, 54). However, memory CD8 T cells undergo attrition in total numbers when mice are infected with unrelated (heterologous) pathogens or exposed to inflammation (55–57). The extent to which the obese environment (characterized by low levels of systemic inflammation) (6) influences the maintenance of pre-existing memory CD8 T cell responses is currently unknown. To address this, immune B6 Thy1.2+ mice that contained primary memory GP33-specific P14 T-cell-receptor transgenic (TCR-Tg) Thy1.1+/1.2− CD8 T cells were started on a high-fat diet (60% kcal from fat), a month after primary LCMV infection (Fig. 1A-C). Importantly, waiting for 30 days to introduce the high-fat diet ensured two things – clearance of the virus (which usually occurs in the first week post infection (58)) and the establishment of memory CD8 T cell responses upon completion of the contraction phase (19)
Figure 1. Obesity does not impact the maintenance of pre-existing memory CD8 T cells.
A) Experimental design. Naïve B6 Thy1.2+/1.2+ mice received a transfer of naïve Thy1.1+/1.2− P14 CD8 T cells (5×103 cells/mouse, i.v.) and were infected with LCMV (2×105 PFU/mouse, i.p.). 30 days after infection, mice either continued to receive standard chow diet or were started on high-fat diet. B) Representative dot plot showing the percentage of memory P14 CD8 T cells in the PBL day 30 after infection. C) Blood samples were pooled, and the expression of CD27, CD62L, or KLRG1 molecules was evaluated individually on memory P14 CD8 T cells day 30 after infection. Shaded graph represents isotype control staining and open graphs represent specific Ab staining on gated P14 cells. D) Weight of lean and obese mice 120 days after high-fat diet. Dots represent individual mice and the lines represent the mean and SD. E) The percentage of memory P14 CD8 T cells in the PBL of individual lean and obese mice 120 days after high-fat diet. F) The percentage of memory P14 CD8 T cells in lean and obese mice expressing CD27, or CD62L, or KLRG1 120 days after high-fat diet. G) Representative dot plots showing cytokine production by memory P14 CD8 T cells, isolated from the PBL of lean and obese mice 120 days after high-fat diet, after short ex vivo incubation in the presence of EL-4 thymoma cells (H-2b MHC) as antigen-presenting cells and GP33 peptide. Numbers represent the percentage of memory P14 CD8 T cells positive for IFNγ and TNFα or IL-2. Representative histograms showing the percentage of IFNγ+ memory P14 CD8 T cells in the PBL of lean and obese mice expressing H) Granzyme B or I) CD107a following ex vivo incubation with GP33. Shaded graph represents isotype control staining and open graphs represent staining on gated memory P14 CD8 T cells. Data are of 6–9 mice per group and representative of three independent and similar experiments. Weight graph is presented as scatter dot plot with mean±SD. Data presented as bar graphs are presented as mean±SEM. Representative dot plot is presented as mean±SEM. Representative histogram is presented as mean±SEM.
Within 120 days of receiving high-fat diet, mice had gained a significant amount of weight and become obese (as defined by body weight greater than 3 SD above the mean weight of age-matched LCMV-immune lean B6 mice that were given standard chow diet (6.2% kcal from fat) for the duration of the experiment (41, 59) (Fig. 1D)). Interestingly, similar frequencies of memory P14 CD8 T cells were detected in the peripheral blood (PBL) of lean and obese mice suggesting that diet-induced obesity did not influence the ability of the host to maintain its memory CD8 T cell numbers (Fig. 1E). In addition, time-dependent changes in the phenotype of memory P14 cells (increase in CD27 and CD62L and decrease in KLRG-1 expression (20, 28)) were observed from day 30 (start of the high-fat diet) to day 150 after LCMV infection. Importantly, those changes occurred at similar rates in memory CD8 T cells detected in both lean and obese groups (Fig. 1C,F). A similar percentage of P14 cells from lean and obese mice produced effector cytokines such as IFNγ, TNFα and IL-2 after ex vivo GP33 peptide stimulation (Fig. 1G). Finally, the cytolytic potential of memory CD8 T cells defined by the expression of Granzyme B and CD107a, a marker of degranulation (45), was similar in both groups of mice (Fig. 1H,I). Thus, these data suggest that diet-induced obesity does not influence the number, phenotype, or function of memory CD8 T cells generated before the onset of obesity.
Obesity does not impact the generation and maintenance of newly evoked memory CD8 T cell responses
In order to investigate the extent to which the obese environment impacts the generation and differentiation of newly evoked memory CD8 T cells, groups of LCMV-immune lean and diet-induced obese B6 mice (initially described in Figure 1) were adoptively transferred with naïve Ova257-specific OT-I TCR-Tg CD8 T cells (29). Low numbers of naïve Thy1.1+/1.2+ OT-I cells (1×103 cells/mouse), obtained from lean TCR-Tg mice, were seeded into recipient mice one day before infection with attenuated L. monocytogenes strain expressing Ova257 epitope (Att Lm-Ova; Fig. 2A)(29). This experimental set-up also allowed for continuous monitoring of the LCMV-specific memory P14 cell responses (Thy1.1+/1.2−) that were generated before the onset of obesity (Fig. 2A,B). Examination of OT-I CD8 T cells in the blood revealed that the obese environment did not influence the magnitude of proliferative expansion and accumulation of Ova257-specific effector CD8 T cells (Fig. 2C). L. monocytogenes-specific memory CD8 T cells in lean and diet-induced obese hosts persisted at similar numbers (Fig. 2D) and underwent time-dependent changes in their phenotype at similar rates (Fig. 2E and Suppl. Fig. 1A). Also, continuous high-fat diet did not influence the long-term maintenance and function of LCMV-specific P14 CD8 T cells. The number (determined in PBL and secondary lymphoid organs- Fig. 2F, Suppl. Fig. 1C), phenotype (Fig. 2G and Suppl. Fig. 1B), and function (peptide stimulated IFNγ, TNFα and IL-2 production- Fig. 3A) of memory P14 CD8 T cells detected in lean and diet-induced obese hosts were indistinguishable. Finally, to test whether memory CD8 T cell in obese hosts have an impaired ability to control secondary infection, both groups of mice were challenged with attenuated L. monocytogenes strain expressing GP33 epitope (Att LM-GP33- Fig. 3B). L. monocytogenes was used for secondary infection since anti-Listerial immunity is predominately mediated by CD8 T cells (60). Since the number of memory CD8 T cells present at the time of re-infection correlates with the level of CD8 T cell-mediated protection (21, 25–27), total numbers of endogenous and TCR-Tg GP33-specific CD8 T cells were determined by DbGP33 tetramers to document that LCMV-immune lean and diet-induced obese mice contained similar percentages of GP33-specific CD8 T cells (Fig. 3C,D). Importantly, both groups of immune mice were able to clear L. monocytogenes infection at day 2 post challenge (Fig. 3E), suggesting that CD8 T cell-mediated immunity was not impaired by obesity.
Figure 2. Obesity does not impact the generation and maintenance of newly evoked memory CD8 T cell responses.
A) Experimental design. LCMV immune lean and obese mice containing memory Thy1.1+/1.2− P14 CD8 T cells received a transfer of naïve Thy1.1+/1.2+ OT-I CD8 T cells (1×103 cells/mouse, i.v.) one day before Att LM-Ova infection (5×106 CFU/mouse, i.v.). B) Representative dot plot showing the percentage of memory Thy1.1+/1.2− P14 and effector Thy1.1+/1.2+ OT-I CD8 T cells in the PBL of lean and obese mice 7 days after LM challenge. The frequency of OT-I cells in the PBL of individual mice at C) day 7 and at D) day 60 after bacterial infection. E) The percentage of memory OT-I CD8 T cells in lean and obese mice expressing CD27, or CD62L, or KLRG1 at day 60 p.i. F) The percentage of memory P14 CD8 T cells in the PBL of individual lean and obese mice 216 days after LCMV infection. G) The percentage of memory P14 CD8 T cells in lean and obese mice expressing CD27, or CD62L, or KLRG1 at day 216 after LCMV infection. Data are of 6 mice per group and representative of three independent and similar experiments. Data presented as bar graphs are presented as mean±SEM.
Figure 3. The protective function of memory CD8 T cells is not impacted by obesity.
A) Representative dot plots showing cytokine production by memory P14 CD8 T cells, isolated from the spleen of individual lean and obese mice at day 236 after LCMV infection, after short ex vivo incubation in the presence of GP33 peptide. Numbers represent the percentage of memory P14 CD8 T cells that were positive for IFNγ and TNFα or IL-2. B) Experimental design. At day 236 after infection, LCMV immune lean and obese mice containing memory P14 CD8 T cells were challenged with Vir LM-GP33 (2×105 CFU/mouse, i.v.). C) Representative dot plots showing the frequency of tetramer+ (DbGP33) GP33-specific memory CD8 T cells in the PBL. D) The percentage of GP33-specific CD8 T cells in the PBL of individual lean and obese mice on the day of challenge. E) Bacterial titers in the spleen (CFU/spleen) were determined 2 days after Vir LM-GP33 infection. Data are presented as mean of 3–5 mice per group. Dashed line represents the limit of detection (LOD). Data are of 3–5 mice per group and representative of two independent and similar experiments. Representative dot plot is presented as mean±SEM. Data presented as bar graph is presented as mean±SEM.
Taken together, these data suggest that the obese environment does not influence the development or maintenance of memory CD8 T cell responses that are either primed before or after obesity is established.
Endogenous CD8 T cell responses to systemic and localized viral and bacterial infections are not influenced by diet-induced obesity
In the studies above, we utilized adoptive transfers of naïve TCR-Tg CD8 T cell precursors obtained from lean Tg hosts to determine the extent to which obesity influences the development and maintenance of memory CD8 T cell responses. To determine whether obesity alters the ability of naïve endogenous CD8 T cell precursors to respond to infection and develop into memory CD8 T cells, endogenous pathogen-specific CD8 T cell responses were analyzed after systemic and localized viral or bacterial infections. After receiving high-fat diet for 100 days, diet-induced obese B6 mice and age-matched lean control mice were infected with LCMV (Fig. 4A,B). Similar percentages of endogenous DbGP33-specific CD8 T cells were detected in the blood of lean and obese hosts at a memory time point (day 110 post infection) (Fig. 4C,D). In addition, the expression of surface markers associated with memory CD8 T cell development (i.e. CD27, CD62L, and KLRG1) was indistinguishable between GP33-specific memory CD8 T cells from both groups of mice (Fig. 4E). Finally, to determine if endogenous memory CD8 T cells primed in a lean or obese environment differ in their ability to undergo Ag-stimulated secondary expansion, LCMV-immune mice were challenged with virulent L. monocytogenes expressing GP33 epitope (Vir LM-GP33) (Fig. 4F). The magnitude of secondary expansion of GP33-specific CD8 T cells, detected in the blood at day 5 post secondary challenge, was not significantly different between lean and obese mice (Fig. 4G,H), suggesting that the capacity of memory CD8 T cells to respond to secondary challenge was not impaired by diet-induced obesity. Similar data were obtained after systemic bacterial infection as well (Supp. Fig. 2). Obesity did not impact the number, phenotype, or function of bacteria-specific memory CD8 T cells generated after infection with virulent L. monocytogenes expressing Ova epitope (Vir LM-Ova) (Supp. Fig. 2A-F). There fore, obesity does not change the ability of naïve CD8 T cell precursors to respond to systemic infections and develop into functional memory CD8 T cells.
Figure 4. Obesity does not influence the generation and function of endogenous virus-specific memory CD8 T cells.
A) Experimental design. Naïve B6 lean and obese mice were infected with LCMV (2×105 PFU/mouse, i.p.). B) Weight of lean and obese mice 100 days after high-fat diet. Dots represent individual mice and the lines represent the mean and SD. C) Representative dot plots showing the percentage of tetramer+ (DbGP33) endogenous GP33-specific memory CD8 T cells in the PBL at day 110 post infection. D) The frequency of endogenous GP33-specific memory CD8 T cells in the PBL at day 110 p.i. E) The percentage of endogenous GP33-specific memory CD8 T cells expressing CD27, or CD62L, or KLRG1 molecules. F) Experimental design. At day 112 after infection, LCMV immune lean and obese mice were challenged with Vir LM-GP33 (1×105 CFU/mouse, i.v.). G) Representative dot plots showing the percentage of endogenous GP33-specific secondary effector CD8 T cells in the PBL at day 5 after challenge. H) The percentage of GP33-specific secondary effector CD8 T cells in the PBL of individual lean and obese mice at day 5 after challenge. Data are of 3 mice per group and representative of three similar and independent experiments. Weight graph is presented as scatter dot plot with mean±SD. Data presented as bar graphs are presented as mean±SEM.
Previous studies suggested, although never directly tested, that diet-induced obesity influences the development of memory CD8 T cells following localized influenza virus (IAV) infection(61–63). Following IAV PR8 infection (Supp. Fig 3A,B), the magnitude of proliferative expansion of endogenous DbNP366-specific (Supp. Fig. 3C, D) and DbPA224-specific (data not shown) CD8 T cells was similar in the PBL of individual lean and obese mice. In addition, evaluating the total numbers of memory NP366 and PA224-specific CD8 T cells in various tissues, including the lung and spleen, day 30 after infection (Supp. Fig. 3E,F) revealed that the generation of influenza specific memory CD8 T cells was not impaired in obese hosts. Furthermore, when IAV PR8-immune mice were challenged with the IAV strain X-31 (Supp. Fig. 3G), the magnitude of secondary expansion of NP366-specific CD8 T cells, detected in the blood at day 7 after challenge, was not different between lean and obese mice (Supp. Fig. 3H, I). The accumulation of secondary effector NP366-specific CD8 T cells in the spleen and lungs of lean and obese mice was also similar at day 10 after challenge (Supp. Fig. 3J). Thus, these data suggest that obesity does not influence the generation of memory CD8 T cells after localized influenza A virus infection and their ability to respond to a secondary challenge with cognate Ag delivered in the context of infection.
Continuous high-fat diet does not impair the generation of memory CD8 T cell responses in outbred mice
Recently, we identified a ‘surrogate activation marker approach’ to identify CD8 T cell responses without a priori knowledge of specific epitopes or MHC restriction elements that enabled longitudinal analysis of pathogen-specific CD8 T cell responses in outbred populations(48). We observed substantial variability in the kinetics and magnitude of CD8 T cell responses to various types of infections in genetically diverse outbred mice(48, 64). In order to extend our analysis and verify results obtained in inbred obese B6 mice, we performed similar experiments in which endogenous memory CD8 T cell responses to systemic LCMV infection were analyzed in cohorts of outbred Swiss Webster (SW) mice (Fig. 5). Groups of SW mice were either placed on a high-fat diet or remained on a standard diet for 120 days before LCMV infection (Fig. 5A). Within this time frame, a majority of SW mice receiving the special diet had gained weight, although a substantial variability in weight in both groups of mice was observed (Fig. 5B). Using this ‘surrogate activation marker approach’, endogenous pathogen-specific CD8 T cells were detected within the CD11ahi population of CD8 T cells (Fig. 5C and (48)). As previously observed, the magnitude of the memory CD8 T cell response (day 60 post infection) in LCMV immune outbred mice receiving a standard diet was not uniform and varied widely, however, a similar pattern was observed in individual SW mice that were kept on a high-fat diet (Fig. 5D). Interestingly, we found no correlation between the magnitude of the CD8 T cell response and the weight of mice either receiving the standard or high-fat diet (data not shown). This suggests that whether an outbred mouse gains excessive weight receiving a standard or high-fat diet, the magnitude of the CD8 T cell response after infection is not impacted. Additionally, a similar composition of Ag-experienced memory CD8 T cells expressing CD62L and CD27 were found in both groups of mice (Fig. 5E). Thus, these data show that despite the numerical variability in LCMV-induced memory CD8 T cells in outbred hosts, continuous high-fat diet and excessive weight gain does not influence their generation and differentiation after systemic viral infection.
Figure 5. Continuous high-fat diet does not impair the generation of memory CD8 T cell responses in outbred mice.
A) Experimental design. Naïve outbred SW mice either receiving high-fat diet (HFD) or standard diet (SD) were infected with LCMV (2×105 PFU/mouse, i.p.). B) Weight of mice 120 days after high-fat diet. Dots represent individual mice and the lines represent the mean and SD. C) Representative dot plot showing Ag-experienced (CD11ahi CD8αlow) and Ag-in experienced (CD11alow CD8αhi) CD8 T cells 60 days after infection. Representative histograms showing expression of CD62L and KLRG1 molecules on CD11ahi and CD11alow CD8 T cells at day 60 after infection. D) The frequency of CD11ahi CD8αlow memory CD8 T cells in the PBL at day 60 after infection. Dots represent individual mice and the line represents the mean. E) The percentage of LCMV-specific memory CD8 T cells in the PBL of individual mice expressing CD62L or KLRG1. Data are of 10–14 mice per group. Weight graph is presented as scatter dot plot with mean±SD.
Obesity associated inflammation does not prevent accelerated memory differentiation of Ag-specific CD8 T cells after immunization with peptide-coated dendritic cells
Recent studies, including our own, demonstrate that pro-inflammatory cytokines act directly on Ag-specific CD8 T cells to affect crucial aspects of memory CD8 T cell generation(19). ‘Signal 3’ inflammatory cytokines, such as IL-12 and type I IFNs, can influence the proliferative expansion, program of contraction, and rate of memory differentiation of responding CD8 T cells(22, 24, 28, 29, 31, 33, 65). Infection of mice with intracellular pathogens such as LCMV and L. monocytogenes stimulate robust CD8 T cells that initially exhibit an effector phenotype (i.e. GranzymeBhi, CD127low, KLRG-1hi) and acquire memory phenotype and function relatively slowly after the infection/inflammation is cleared(19, 20). In contrast, immunization with peptide-coated mature dendritic cells (DC) in the absence of additional adjuvants evokes CD8 T cells that display memory characteristics (i.e. GranzymeBlow, CD127hi, KLRG-1low expression and ability to undergo robust proliferative expansion in response to secondary Ag-challenge) within days of initial priming(30, 32, 66). Thus, the inflammatory environment at the time of naïve CD8 T cell priming determines the rate of naïve-to-memory CD8 T cell differentiation.
Numerous studies suggest that the extent of metabolic dysfunction observed in obese hosts directly correlates with increased levels of pro-inflammatory cytokines in the periphery(35, 37, 41, 67, 68). In order to confirm that prolonged high-fat diet leads to increases in systemic inflammation, plasma from naïve (non-immunized) lean and diet-induced obese B6 mice was tested for concentrations of the indicated cytokines/chemokines via multiplex array (Fig. 6A). The results showed that concentrations of most of the analyzed analytes were increased in the plasma of obese hosts (Fig. 6A). However, in lean and diet-induced obese hosts the classical ‘signal 3’ cytokine IL-12 was below the limit of detection, while it was significantly increased in the plasma of the control lean mice after L. monocytogenes infection (Fig. 6A and data not shown). Thus, the absence of measurable differences in plasma concentrations of ‘signal 3’ cytokines in the lean and obese hosts suggest that priming of naïve CD8 T cells and their differentiation into the memory CD8 T cell pool would occur at similar rates despite the overall differences in the systemic inflammation.
Figure 6. Obesity associated inflammation does not prevent accelerated memory differentiation of Ag-specific CD8 T cells after immunization with peptide-coated dendritic cells.
A) Plasma, collected from naïve lean and obese B6 mice 130 days after high-fat diet, was tested via Multiplex analysis to determine concentrations (pg/mL) of the indicated cytokines and chemokines. Data are presented as mean of 11–12 mice per group. Dashed line represents the limit of detection (LOD). Statistical significance was determined when concentrations of analytes were above the LOD in both groups. B) Experimental design. Naïve lean and obese B6 mice were immunized with DCs coated with Ova peptide (5×105 DCs/mouse, i.v.). An additional control group of lean mice received DC-Ova with coinjection of CpG (100 μg, i.p.). Ag-specific CD8 T cells were analyzed in the PBL at day 7 post immunization. Mice were boosted with Att LM-Ova (1×107 CFU/mouse, i.v.) and the percentage of endogenous tetramer+ (KbOva) endogenous Ova-specific CD8 T cells were analyzed 5 days later. C) Weight of mice 130 days after high-fat diet. Dots represent individual mice and the lines represent the mean and SD. D) The frequency of tetramer+ (KbOva) endogenous Ova-specific CD8 T cells in the PBL of individual mice at day 7 after immunization. E) The percentage of Ova-specific CD8 T cells expressing KLRG1 and Granzyme B at day 7 after immunization with DC-Ova in the presence or absence of CpG coinjection. F) Representative dot plots showing the percentage of Ova-specific CD8 T cells in the PBL at day 5 after LM infection. G) The percentage of Ova-specific CD8 T cells in the PBL of individual lean and obese mice 5 days after booster infection. Data in B–G are of 4–6 mice per group and representative of four independent and similar experiments. Weight graph is presented as scatter dot plot with mean±SD. Data presented as bar graphs are presented as mean±SEM. Representative histogram is presented as mean±SEM.
To explore that obesity-associated systemic inflammation does not influence naïve-to-memory CD8 T cell differentiation, we used a peptide-coated DC immunization strategy that induces substantially less inflammation than systemic LCMV or L. monocytogenes infections(30). Lean and obese groups of mice were immunized with lipopolysaccharide (LPS)-matured DCs coated with Ova257 peptide (DC-Ova). An additional group of lean mice was introduced into the experiment to serve as a positive control in which inflammation, including high levels of IL-12, was induced by injection of the TLR9 agonist CpG(30, 32) at the time of DC-Ova immunization(Fig. 6B,C). This experimental model allowed us to determine whether obesity-associated inflammation, like adjuvant-induced inflammation (CpG), influenced the rate at which Ag-specific CD8 T cells acquire memory CD8 T cell characteristics(28, 30, 32). Consistent with our previous findings using B6 mice, the magnitude of proliferative expansion of Ova257-specific CD8 T cells responding to DC-immunization in the presence of heightened inflammation (Lean + CpG group) was significantly increased compared to cells activated in the absence of inflammation (Lean group)(32)(Fig. 6D). Whereas Ova257-specific CD8 T cells primed in an obese environment underwent reduced levels of proliferative expansion (even when compared to Lean group alone), these data suggest that obesity-associated inflammatory signals did not act on Ag-specific CD8 T cells to increase their accumulation in vivo (Fig. 6D). Similarly, Ova257-specific CD8 T cells in obese mice displayed an early-memory phenotype (GranzymeBlow, KLRG-1low) (Fig. 6E) and underwent vigorous secondary expansion in response to early (day 7) booster challenge with Att LM-Ova (Fig. 6F,G), indicating that differences in the inflammatory environments of lean and obese hosts receiving peptide-DC immunization alone did not influence the rate of memory CD8 T cell differentiation. Similar data was obtained using a model of diet-induced obesity in BALB/c mice following immunization with mature DCs coated with P. berghei-derived circumsporozoite protein CS252 (Supp. Fig. 4A,B)(49). Obesity-associated inflammation in BALB/c mice did not promote increased accumulation of Ag-specific CD8 T cells (Supp. Fig. 4C,D) and did not inhibit the accelerated memory CD8 T cell differentiation (Supp. Fig. 4E). Collectively, these data suggest that unlike pathogen- or adjuvant-induced inflammation, obesity-associated inflammatory signals do not increase the primary CD8 T cell expansion and delay naïve-to-memory CD8 T cell progression. Alternatively, obesity associated inflammation (as shown in both B6 and BALB/c obese mice) might influence primary CD8 T cell accumulation after peptide-DC immunization, an interesting notion that will be explored in future studies.
Discussion
Here, we show that: I) obesity does not alter the maintenance and protective capacity of pre-existing memory CD8 T cells; II) naïve Ag-specific CD8 T cells originating in obese inbred or outbred hosts are equally capable of responding to systemic or localized infections, suggesting that obesity does not impair the intrinsic ability of CD8 T cells to respond to cognate Ag and develop into memory CD8 T cells; and that III) obesity-mediated alterations in the cytokine milieu does not influence naïve-to-memory CD8 T cell differentiation after peptide-DC immunization.
Although substantial resources are devoted in elucidating obesity-associated factors that influence the overall health status of the host, surprisingly only a small number of studies have been published to date that explored the role of obesity in the development and maintenance of pathogen-specific CD8 T cell responses. Work by Beck’s group suggests that after localized influenza infection, memory CD8 T cell function may be impaired in diet-induced obese hosts. In contrast to our findings, Karlsson et al. found that the capacity of influenza-specific CD8 T cells to undergo secondary expansion after diet-induced obese mice were first primed with the H3N2 (X-31) strain of influenza and then challenged with the H1N1 (PR8) strain was reduced (63). Potential differences in experimental models used in both studies that can contribute to different results observed are dose and strain of IAV used as primary challenge, the absence of detailed characterization of X-31 induced memory CD8 T cells (quantity, phenotype and function), and the high-fat diet used throughout the experiments.
Our longitudinal analysis of pre-existing GP33-specific memory CD8 T cells in LCMV-immune mice suggests that time-dependent changes in phenotype and function, including differential expression of phenotypic markers and capacity to exert effector function, are not impacted by the onset of obesity. We also found that naïve TCR-Tg OT-I CD8 T cells that originated in a lean Tg host developed into functional memory CD8 T cells when primed in a lean or obese host, suggesting that the obese environment does not impact the ability of Ag-specific CD8 T cells to respond to cognate Ag.
Results from the Dixit group suggest that diet-induced obesity accelerates thymic aging and decreases the diversity of the T cell repertoire (69, 70). Since it has been previously shown that age-associated changes in naïve T cell precursors compromise infection-induced immune responses due to a specific loss in CD8 T cells(71), it is possible that diet-induced mice have an altered CD8 T cell repertoire, which may increase their susceptibility to infection. Recent studies from our lab also show that sepsis-stimulated systemic inflammatory responses induce rapid apoptosis of naïve CD8 T cells that can ultimately lead to stochastic changes in the composition of the naïve CD8 T cell repertoire and/or render post-septic hosts unable to effectively mount primary CD8 T cell responses to some but not all pathogen-derived antigens (72). To test if obese hosts are more susceptible to infection due to the changes in naïve CD8 T cell precursors present in the obese environment, we analyzed endogenous primary CD8 T cell responses after systemic and localized viral or bacterial infections. Interestingly, regardless of the type or route of infection, pathogen-specific primary CD8 T cell responses were similar in lean and obese hosts. Specifically, the magnitude of proliferative expansion and effector CD8 T cell generation, acquisition of memory phenotype and function, and capacity to undergo secondary expansion upon additional Ag-encounter were similar when endogenous CD8 T cell responses were compared in lean and obese mice. In addition, analysis of endogenous pathogen-specific CD8 T cell responses in cohorts of outbred SW mice also revealed that patterns of memory differentiation were undisturbed in outbred mice continuously receiving a high-fat diet. In summary, these data suggest that diet-induced obesity did not change the overall capacity of the host’s naïve CD8 T cells to respond to new infections.
As previously reported, we also found that obese hosts have increased systemic levels of various cytokines and/or chemokines (34–36). Interestingly, diet-induced obesity triggered low-grade systemic inflammation did not include detectable alterations in ‘signal 3’ cytokines. It has been shown by us and others that infection-induced ‘signal 3’ cytokines such as IL-12 provide signals that shape all phases of primary Ag-specific CD8 T cell responses including their expansion and effector CD8 T cells accumulation, degree of contraction, and memory CD8 T cell differentiation (19, 28–33). However, using a model of peptide-DC vaccination (used here as model of antigen delivery that does not evoke an excessive inflammatory response that is detected after infection (30)) to evoke endogenous CD8 T cells we showed that DC-primed CD8 T cells acquired memory-like characteristics at accelerated rates in lean and diet-induced obese hosts, despite differences in systemic inflammation. These preliminary data suggest that although levels of inflammatory signals are increased in obese hosts, these inflammatory signals are unlike pathogen- or adjuvant-induced inflammation and do not influence naïve-to-memory CD8 T cell differentiation. Studies in the future will be designed to further explore the contribution, if any, of various obesity-induced inflammatory signals in T cell homeostasis.
In conclusion, we utilized a variety of experimental models to study the effects of obesity on Ag-specific CD8 T cell responses, and found that obese hosts do not have an impaired ability to generate and sustain protective memory CD8 T cell responses after systemic or localized infections. Increasing our understanding of the obesity-induced effects on CD8 T cell homeostasis has important clinical implications, which may help design future immune-based approaches needed to efficiently fight against infections.
Supplementary Material
Acknowledgments
We thank Deepa Rai for technical assistance and all members of our laboratories for helpful discussions.
Footnotes
Supported by National Institutes of Health Grant (AI83286), National Cancer Institute of the National Institutes of Health under Award Number P30CA086862, and National Institutes of Health Grant (T32 AI007485).
References
- 1.Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA : the journal of the American Medical Association. 2012;307:491–497. doi: 10.1001/jama.2012.39. [DOI] [PubMed] [Google Scholar]
- 2.Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA : the journal of the American Medical Association. 2002;288:1723–1727. doi: 10.1001/jama.288.14.1723. [DOI] [PubMed] [Google Scholar]
- 3.Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature reviews. Cancer. 2004;4:579–591. doi: 10.1038/nrc1408. [DOI] [PubMed] [Google Scholar]
- 4.Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. The New England journal of medicine. 2003;348:1625–1638. doi: 10.1056/NEJMoa021423. [DOI] [PubMed] [Google Scholar]
- 5.Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29:2959–2971. doi: 10.1093/eurheartj/ehn387. [DOI] [PubMed] [Google Scholar]
- 6.Kanneganti TD, Dixit VD. Immunological complications of obesity. Nature immunology. 2012;13:707–712. doi: 10.1038/ni.2343. [DOI] [PubMed] [Google Scholar]
- 7.Mathieu P, Pibarot P, Larose E, Poirier P, Marette A, Despres JP. Visceral obesity and the heart. Int J Biochem Cell Biol. 2008;40:821–836. doi: 10.1016/j.biocel.2007.12.001. [DOI] [PubMed] [Google Scholar]
- 8.Mathieu P, Poirier P, Pibarot P, Lemieux I, Despres JP. Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension. 2009;53:577–584. doi: 10.1161/HYPERTENSIONAHA.108.110320. [DOI] [PubMed] [Google Scholar]
- 9.Mathis D, Shoelson SE. Immunometabolism: an emerging frontier. Nature reviews. Immunology. 2011;11:81. doi: 10.1038/nri2922. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999–2010. JAMA : the journal of the American Medical Association. 2012;307:483–490. doi: 10.1001/jama.2012.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Organization WH. Obesity and overweight. Media Centre Factsheet 2012 [Google Scholar]
- 12.Fezeu L, Julia C, Henegar A, Bitu J, Hu FB, Grobbee DE, Kengne AP, Hercberg S, Czernichow S. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2011;12:653–659. doi: 10.1111/j.1467-789X.2011.00864.x. [DOI] [PubMed] [Google Scholar]
- 13.Kopelman PG. Obesity as a medical problem. Nature. 2000;404:635–643. doi: 10.1038/35007508. [DOI] [PubMed] [Google Scholar]
- 14.Canturk Z, Canturk NZ, Cetinarslan B, Utkan NZ, Tarkun I. Nosocomial infections and obesity in surgical patients. Obes Res. 2003;11:769–775. doi: 10.1038/oby.2003.107. [DOI] [PubMed] [Google Scholar]
- 15.Pierpont YN, Dinh TP, Salas RE, Johnson EL, Wright TG, Robson MC, Payne WG. Obesity and Surgical Wound Healing: A Current Review. ISRN Obes. 2014;2014:638936. doi: 10.1155/2014/638936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA : the journal of the American Medical Association. 1985;254:3187–3189. [PubMed] [Google Scholar]
- 17.Eliakim A, Schwindt C, Zaldivar F, Casali P, Cooper DM. Reduced tetanus antibody titers in overweight children. Autoimmunity. 2006;39:137–141. doi: 10.1080/08916930600597326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB, Holland LA, Weir S, Noah TL, Beck MA. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond) 2012;36:1072–1077. doi: 10.1038/ijo.2011.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Harty JT, Badovinac VP. Shaping and reshaping CD8+ T-cell memory. Nature reviews. Immunology. 2008;8:107–119. doi: 10.1038/nri2251. [DOI] [PubMed] [Google Scholar]
- 20.Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nature reviews. Immunology. 2002;2:251–262. doi: 10.1038/nri778. [DOI] [PubMed] [Google Scholar]
- 21.Nolz JC, Harty JT. Strategies and implications for prime-boost vaccination to generate memory CD8 T cells. Advances in experimental medicine and biology. 2011;780:69–83. doi: 10.1007/978-1-4419-5632-3_7. [DOI] [PubMed] [Google Scholar]
- 22.Jameson SC, Masopust D. Diversity in T cell memory: an embarrassment of riches. Immunity. 2009;31:859–871. doi: 10.1016/j.immuni.2009.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Lefrancois L, Marzo AL. The descent of memory T-cell subsets. Nature reviews. Immunology. 2006;6:618–623. doi: 10.1038/nri1866. [DOI] [PubMed] [Google Scholar]
- 24.Williams MA, Bevan MJ. Effector and memory CTL differentiation. Annu Rev Immunol. 2007;25:171–192. doi: 10.1146/annurev.immunol.25.022106.141548. [DOI] [PubMed] [Google Scholar]
- 25.Badovinac VP, Porter BB, Harty JT. Programmed contraction of CD8(+) T cells after infection. Nature immunology. 2002;3:619–626. doi: 10.1038/ni804. [DOI] [PubMed] [Google Scholar]
- 26.Pope C, Kim SK, Marzo A, Masopust D, Williams K, Jiang J, Shen H, Lefrancois L. Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection. J Immunol. 2001;166:3402–3409. doi: 10.4049/jimmunol.166.5.3402. [DOI] [PubMed] [Google Scholar]
- 27.Schmidt NW, Podyminogin RL, Butler NS, Badovinac VP, Tucker BJ, Bahjat KS, Lauer P, Reyes-Sandoval A, Hutchings CL, Moore AC, Gilbert SC, Hill AV, Bartholomay LC, Harty JT. Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proceedings of the National Academy of Sciences of the United States of America. 2008;105:14017–14022. doi: 10.1073/pnas.0805452105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Haring JS, Badovinac VP, Harty JT. Inflaming the CD8+ T cell response. Immunity. 2006;25:19–29. doi: 10.1016/j.immuni.2006.07.001. [DOI] [PubMed] [Google Scholar]
- 29.Badovinac VP, Haring JS, Harty JT. Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection. Immunity. 2007;26:827–841. doi: 10.1016/j.immuni.2007.04.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Badovinac VP, Messingham KA, Jabbari A, Haring JS, Harty JT. Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination. Nature medicine. 2005;11:748–756. doi: 10.1038/nm1257. [DOI] [PubMed] [Google Scholar]
- 31.Badovinac VP, Porter BB, Harty JT. CD8+ T cell contraction is controlled by early inflammation. Nature immunology. 2004;5:809–817. doi: 10.1038/ni1098. [DOI] [PubMed] [Google Scholar]
- 32.Pham NL, Badovinac VP, Harty JT. A default pathway of memory CD8 T cell differentiation after dendritic cell immunization is deflected by encounter with inflammatory cytokines during antigen-driven proliferation. J Immunol. 2009;183:2337–2348. doi: 10.4049/jimmunol.0901203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Starbeck-Miller GR, Xue HH, Harty JT. IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo. The Journal of experimental medicine. 2014;211:105–120. doi: 10.1084/jem.20130901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nature reviews. Immunology. 2011;11:85–97. doi: 10.1038/nri2921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415–445. doi: 10.1146/annurev-immunol-031210-101322. [DOI] [PubMed] [Google Scholar]
- 36.Kaminski DA, Randall TD. Adaptive immunity and adipose tissue biology. Trends Immunol. 2010;31:384–390. doi: 10.1016/j.it.2010.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Rausch ME, Weisberg S, Vardhana P, Tortoriello DV. Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int J Obes (Lond) 2008;32:451–463. doi: 10.1038/sj.ijo.0803744. [DOI] [PubMed] [Google Scholar]
- 38.Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. The Journal of clinical investigation. 2007;117:175–184. doi: 10.1172/JCI29881. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes. 2007;56:16–23. doi: 10.2337/db06-1076. [DOI] [PubMed] [Google Scholar]
- 40.Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nature reviews. Immunology. 2011;11:723–737. doi: 10.1038/nri3073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.James BR, Tomanek-Chalkley A, Askeland EJ, Kucaba T, Griffith TS, Norian LA. Diet-induced obesity alters dendritic cell function in the presence and absence of tumor growth. J Immunol. 2012;189:1311–1321. doi: 10.4049/jimmunol.1100587. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Brundage RA, Smith GA, Camilli A, Theriot JA, Portnoy DA. Expression and phosphorylation of the Listeria monocytogenes ActA protein in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America. 1993;90:11890–11894. doi: 10.1073/pnas.90.24.11890. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Wirth TC, Xue HH, Rai D, Sabel JT, Bair T, Harty JT, Badovinac VP. Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8 (+) T cell differentiation. Immunity. 2010;33:128–140. doi: 10.1016/j.immuni.2010.06.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Legge KL, Braciale TJ. Lymph node dendritic cells control CD8+ T cell responses through regulated FasL expression. Immunity. 2005;23:649–659. doi: 10.1016/j.immuni.2005.11.006. [DOI] [PubMed] [Google Scholar]
- 45.Messingham KA, Badovinac VP, Jabbari A, Harty JT. A role for IFN-gamma from antigen-specific CD8+ T cells in protective immunity to Listeria monocytogenes. J Immunol. 2007;179:2457–2466. doi: 10.4049/jimmunol.179.4.2457. [DOI] [PubMed] [Google Scholar]
- 46.Masopust D, Murali-Krishna K, Ahmed R. Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: it is even bigger than we thought. Journal of virology. 2007;81:2002–2011. doi: 10.1128/JVI.01459-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Brincks EL, Gurung P, Langlois RA, Hemann EA, Legge KL, Griffith TS. The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL. J Immunol. 2011;187:4581–4588. doi: 10.4049/jimmunol.1002241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Rai D, Pham NL, Harty JT, Badovinac VP. Tracking the total CD8 T cell response to infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts. J Immunol. 2009;183:7672–7681. doi: 10.4049/jimmunol.0902874. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Schmidt NW, Butler NS, Harty JT. Plasmodium-host interactions directly influence the threshold of memory CD8 T cells required for protective immunity. J Immunol. 2011;186:5873–5884. doi: 10.4049/jimmunol.1100194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Jabbari A, Harty JT. Secondary memory CD8+ T cells are more protective but slower to acquire a central-memory phenotype. The Journal of experimental medicine. 2006;203:919–932. doi: 10.1084/jem.20052237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Martin MD, Condotta SA, Harty JT, Badovinac VP. Population dynamics of naive and memory CD8 T cell responses after antigen stimulations in vivo. J Immunol. 2012;188:1255–1265. doi: 10.4049/jimmunol.1101579. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Masopust D, Ha SJ, Vezys V, Ahmed R. Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination. J Immunol. 2006;177:831–839. doi: 10.4049/jimmunol.177.2.831. [DOI] [PubMed] [Google Scholar]
- 53.Homann D, Teyton L, Oldstone MB. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nature medicine. 2001;7:913–919. doi: 10.1038/90950. [DOI] [PubMed] [Google Scholar]
- 54.Valkenburg SA, Venturi V, Dang TH, Bird NL, Doherty PC, Turner SJ, Davenport MP, Kedzierska K. Early priming minimizes the age-related immune compromise of CD8 (+) T cell diversity and function. PLoS pathogens. 2012;8:e1002544. doi: 10.1371/journal.ppat.1002544. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Vezys V, Yates A, Casey KA, Lanier G, Ahmed R, Antia R, Masopust D. Memory CD8 T-cell compartment grows in size with immunological experience. Nature. 2009;457:196–199. doi: 10.1038/nature07486. [DOI] [PubMed] [Google Scholar]
- 56.Schmidt NW, Harty JT. Cutting edge: attrition of Plasmodium-specific memory CD8 T cells results in decreased protection that is rescued by booster immunization. J Immunol. 2011;186:3836–3840. doi: 10.4049/jimmunol.1003949. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Selin LK, Lin MY, Kraemer KA, Pardoll DM, Schneck JP, Varga SM, Santolucito PA, Pinto AK, Welsh RM. Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity. 1999;11:733–742. doi: 10.1016/s1074-7613(00)80147-8. [DOI] [PubMed] [Google Scholar]
- 58.Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. Journal of virology. 2003;77:4911–4927. doi: 10.1128/JVI.77.8.4911-4927.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM, Dixit VD. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nature medicine. 2011;17:179–188. doi: 10.1038/nm.2279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Condotta SA, Richer MJ, Badovinac VP, Harty JT. Probing CD8 T cell responses with Listeria monocytogenes infection. Adv Immunol. 2012;113:51–80. doi: 10.1016/B978-0-12-394590-7.00005-1. [DOI] [PubMed] [Google Scholar]
- 61.Karlsson EA, Sheridan PA, Beck MA. Diet-induced obesity in mice reduces the maintenance of influenza-specific CD8+ memory T cells. J Nutr. 2010;140:1691–1697. doi: 10.3945/jn.110.123653. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Smith AG, Sheridan PA, Tseng RJ, Sheridan JF, Beck MA. Selective impairment in dendritic cell function and altered antigen-specific CD8+ T-cell responses in diet-induced obese mice infected with influenza virus. Immunology. 2009;126:268–279. doi: 10.1111/j.1365-2567.2008.02895.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Karlsson EA, Sheridan PA, Beck MA. Diet-induced obesity impairs the T cell memory response to influenza virus infection. J Immunol. 2010;184:3127–3133. doi: 10.4049/jimmunol.0903220. [DOI] [PubMed] [Google Scholar]
- 64.Schmidt NW, Butler NS, Badovinac VP, Harty JT. Extreme CD8 T cell requirements for anti-malarial liver-stage immunity following immunization with radiation attenuated sporozoites. PLoS pathogens. 2010;6:e1000998. doi: 10.1371/journal.ppat.1000998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Joshi NS, Cui W, Chandele A, Lee HK, Urso DR, Hagman J, Gapin L, Kaech SM. Inflammation directs memory precursor and short-lived effector CD8 (+) T cell fates via the graded expression of T-bet transcription factor. Immunity. 2007;27:281–295. doi: 10.1016/j.immuni.2007.07.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Pham NL, Pewe LL, Fleenor CJ, Langlois RA, Legge KL, Badovinac VP, Harty JT. Exploiting cross-priming to generate protective CD8 T-cell immunity rapidly. Proceedings of the National Academy of Sciences of the United States of America. 2010;107:12198–12203. doi: 10.1073/pnas.1004661107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56:1010–1013. doi: 10.2337/db06-1656. [DOI] [PubMed] [Google Scholar]
- 68.Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–867. doi: 10.1038/nature05485. [DOI] [PubMed] [Google Scholar]
- 69.Yang H, Youm YH, Vandanmagsar B, Ravussin A, Gimble JM, Greenway F, Stephens JM, Mynatt RL, Dixit VD. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol. 2010;185:1836–1845. doi: 10.4049/jimmunol.1000021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Yang H, Youm YH, Vandanmagsar B, Rood J, Kumar KG, Butler AA, Dixit VD. Obesity accelerates thymic aging. Blood. 2009;114:3803–3812. doi: 10.1182/blood-2009-03-213595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Yager EJ, Ahmed M, Lanzer K, Randall TD, Woodland DL, Blackman MA. Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. The Journal of experimental medicine. 2008;205:711–723. doi: 10.1084/jem.20071140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Condotta SA, Rai D, James BR, Griffith TS, Badovinac VP. Sustained and incomplete recovery of naive CD8+ T cell precursors after sepsis contributes to impaired CD8+ T cell responses to infection. J Immunol. 2013;190:1991–2000. doi: 10.4049/jimmunol.1202379. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.